Results 101 to 110 of about 435,892 (214)

From regulatory mechanisms to cutting‐edge applications: Research progress of ultrasound, electrical, magnetic, and optical stimulation in neural modulation

open access: yesJournal of Intelligent Medicine, Volume 3, Issue 3, Page 196-219, September 2026.
Abstract In recent years, the clinical treatment and symptom management of neurological disorders have faced significant challenges due to the high complexity of the nervous system's structure and function. Against this backdrop, physical stimulation techniques have emerged as a vital complementary approach to traditional pharmacological treatments and
Wanying Li, Liqun Chen
wiley   +1 more source

Diagnostic value of oral “beefy red” patch in vitamin B12 deficiency

open access: yesTherapeutics and Clinical Risk Management, 2018
Peiru Zhou,1 Hong Hua,1 Zhimin Yan,1 Liwu Zheng,2 Xiaosong Liu1 1Department of Oral Medicine, Peking University School and Hospital of Stomatology, Beijing, China; 2Discipline of Oral Diagnosis and Polyclinics, Faculty of Dentistry, Prince Philip Dental
Zhou P, Hua H, Yan Z, Zheng L, Liu X
doaj  

Vitamin B12 (Cobalamin) Deficiency in Overt and Subclinical Primary Hypothyroidism. [PDF]

open access: yesClin Med Insights Endocrinol Diabetes, 2022
Aon M   +4 more
europepmc   +1 more source

Vitamin B12 (Cobalamin) Deficiency in the Older Adult

open access: yes, 2012
Vitamin B12 (Cobalamin) deficiency in the older adult occurs frequently and has the potential for serious neurological and hematological complications.
Orton, Christine
core   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonist‐Based Agents and Body Composition: Filling More Gaps

open access: yesObesity, Volume 34, Issue S2, Page 51-63, September 2026.
ABSTRACT The last 2 decades have seen historic advances in the treatment of obesity. We are entering an era of defining obesity not by weight‐based outcomes but by changes in body composition. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are forming the platform for obesity treatments based on their high level of efficacy. Body composition can
Robert L. Dubin   +4 more
wiley   +1 more source

Expression of the cobalamin transporters cubam and MRP1 in the canine ileum-Upregulation in chronic inflammatory enteropathy.

open access: yesPLoS ONE
Chronic inflammatory enteropathy (CIE) in dogs, a spontaneous model of human inflammatory bowel disease (IBD), is associated with a high rate of cobalamin deficiency.
Stefanie Kather   +8 more
doaj   +1 more source

Reliable and powerful laboratory markers of cobalamin deficiency in the newborn: plasma and urinary methylmalonic acid

open access: yes, 2016
Background: Diagnosing cobalamin deficiency is critical, given the high prevalence of cobalamin deficiency particularly in developing countries. Measuring serum cobalamin levels is of limited diagnostic sensitivity, in other words its specificity and ...
Kirecci, Ahmet   +6 more
core   +1 more source

Mechanistic Insights Into Hepatotoxicity‐Induced Liver Cirrhosis and Anemia: Iron Dysregulation, the Hepcidin–Ferroportin Axis, and Emerging Therapeutic Strategies

open access: yesOrgan Medicine, Volume 3, Issue 3, Page 171-185, September 2026.
Patients with alcohol‐associated liver cirrhosis or acetaminophen (APAP) toxicity frequently develop anemia with iron metabolism disturbances. Dysregulation of hepcidin–ferroportin signaling, along with inflammation, oxidative stress, hypoxia, impaired intestinal iron absorption, malnutrition, and gastrointestinal bleeding, contributes to anemia ...
Debabrata Dash, Raj Kumar Koiri
wiley   +1 more source

Home - About - Disclaimer - Privacy